Enhancement of the IFN-β-induced host signature informs repurposed drugs for COVID-19

MLA

Chiao Hui Hsieh, et al. “Enhancement of the IFN-β-Induced Host Signature Informs Repurposed Drugs for COVID-19.” Heliyon, vol. 6, Dec. 2020, p. e05646. EBSCOhost, https://doi.org/10.1016/j.heliyon.2020.e05646.

APA

Chiao Hui Hsieh, Sui-Yuan Chang, Hsuan Cheng Huang, Wen Hau Lee, Chen Tsung Huang, Yu Hao Pang, Tai Ling Chao, Hsueh Fen Juan, & Han Chieh Kao. (2020). Enhancement of the IFN-β-induced host signature informs repurposed drugs for COVID-19. Heliyon, 6, e05646. https://doi.org/10.1016/j.heliyon.2020.e05646

Chicago

Chiao Hui Hsieh, Sui-Yuan Chang, Hsuan Cheng Huang, Wen Hau Lee, Chen Tsung Huang, Yu Hao Pang, Tai Ling Chao, Hsueh Fen Juan, and Han Chieh Kao. 2020. “Enhancement of the IFN-β-Induced Host Signature Informs Repurposed Drugs for COVID-19.” Heliyon 6 (December): e05646. doi:10.1016/j.heliyon.2020.e05646.